Search

everythinglearnresearchcommunity

for

Search:↓

The most different genetic segment between Africans and East Asians is the EDA2R/AR region, with two main types influenced by population changes and natural selection, and linked to baldness.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3 levels, suggesting these factors might influence male pattern baldness.

Skin changes throughout life, from development before birth to aging effects like wrinkles, influenced by both genetics and environment.

Androgen-modulating drugs do not significantly change the heat sensitivity of prostate cancer cells.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Eccrine sweat gland's clear cells likely cause excessive sweating in hyperhidrosis.

Suppressing certain hormones might help prevent prostate cancer.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Plant extracts may help treat hormone-related hair loss.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

PCOS is caused by both genetics and environmental factors like diet and obesity.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

TrichoScan helps identify subtle hair thinning in women with androgenetic alopecia.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

Male pattern hair loss negatively affects quality of life, but drug treatments can help.

Spironolactone did not make hair thinner in women with excess hair growth.